Abstract:Six organotin(IV) complexes, viz., [Me2Sn(L)] (1), [n-Bu2Sn(L)] (2), [n-Oct2Sn(L)] (3), [Bz2Sn(L)]·0.5C7H8 (4), [n-BuSn(L)Cl] (5), and [PhSn(L)Cl] (6), were synthesized using a 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone), H2L. Compounds were characterized by Fourier transform infrared (FT-IR), High-resolution mass spectrometry (HRMS), and solutions Fourier transform nuclear magnetic resonance (FT-NMR) spectroscopies. The structures 1-6 were established by single-crystal X-ray diffraction (SC-XRD) analysis. Diffraction results evidenced that complexes 1-6 were seven-coordinated mononuclear species with the equatorial plane comprising the pentagonal N3O2 chelate ring of the doubly deprotonated L and two axial ligands, either R (R = Me, n-Bu, n-Oct, Bz) or R (n-Bu or Ph) and Cl ligands. Additionally, the photophysical properties were examined due to the enhanced conjugation and rigidity of the molecules while thermogravimetric analysis was carried out to evaluate the thermal stabilities of compounds. The anti-proliferative activity of the complexes 1-6 was tested against prostate cancer cells (DU-145) and normal human embryonic kidney cells (HEK-293). Among the compounds, dibutyltin compound 2 exhibited increased anti-proliferative activity, with an IC50 value of 6.16 ± 1.56 μM. The investigation of its mechanism of action involves using AO/EB (acridine orange/ethidium bromide) and ROS (reactive oxygen species) generation assays. This likely detects apoptotic morphological alterations in the nucleus of the cells, with ROS generation ultimately leading to apoptosis and cell death. The superior activity of 2 may be attributed to the C···H contacts and respective higher de outside and di inside distances from the Hirshfeld surface. Thus, these compounds could be a promising alternative to classical chemotherapy agents.

Anticancer activity and DNA-binding of di- o -chlorobenzyltin derivatives

Synthesis, crystal structures, and biological activity of aroylhydrazone di-m-chlorobenzyltin complexes

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Five new diorganotin complexes containing arylformylhydrazone ligands as anticancer agents

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Synthesis, Characterization, DNA Binding and Cleavage, BSA Interaction and Anticancer Activity of Dinuclear Zinc Complexes.

Interaction with Biomacromolecules and Antiproliferative Activities of Mn(Ii), Ni(Ii), Zn(Ii) Complexes of Demethylcantharate and 2,2 '-Bipyridine

Functional copper complexes with benzofurans tridentate ligand: Synthesis, crystal structure, DNA binding and anticancer studies

Design, synthesis and mechanistic studies of novel arylformylhydrazone butylphenyltin complexes as potential anticancer agents

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Organotin(IV) Complexes Derived from Hydrazone Schiff Base: Synthesis, Crystal Structure, in Vitro Cytotoxicity and DNA/BSA Interactions

Synthesis, Characterization, Dna/Bsa Interactions and Anticancer Activity of Achiral and Chiral Copper Complexes

Synthesis, cancer cell antiproliferative and antibacterial activity of zinc hydroxybenzoate complexes of substituted terpyridines

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Synthesis, structural elucidation and anticancer activity of diorganotin(IV) complexes derived from isonicotinoyl hydrazones

Dimethyltin(IV) complexes derived from hydroxamic acid and acylhydrazone ligands: Synthesis, DNA/bovine serum albumin interaction and cytotoxicity

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

Synthesis, Biological Evaluation, and Molecular Docking Studies of Diacylhydrazine Derivatives Possessing 1,4-Benzodioxan Moiety As Potential Anticancer Agents

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Organotin(IV) complexes derived from 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone) as prospective anti-proliferative agents: Synthesis, characterization, structures and in vitro anticancer activity